UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061856
Receipt number R000069964
Scientific Title Ultrathin Cryobiopsy using Direct Retrieval Through the Channel of the Therapeutic Bronchoscope (Cryo-DiReCT) method for diagnosing interstitial lung disease -CRYO-DIRECTION study-
Date of disclosure of the study information 2026/06/10
Last modified on 2026/06/10 12:52:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and Efficacy of Ultrathin Cryobiopsy using Direct Retrieval Through the Channel of the Therapeutic Bronchoscope (Cryo-DiReCT) method for diagnosing interstitial lung disease

Acronym

Ultrathin Cryobiopsy using Direct Retrieval Through the Channel of the Therapeutic Bronchoscope (Cryo-DiReCT) method for diagnosing interstitial lung disease -CRYO-DIRECTION study-

Scientific Title

Ultrathin Cryobiopsy using Direct Retrieval Through the Channel of the Therapeutic Bronchoscope (Cryo-DiReCT) method for diagnosing interstitial lung disease -CRYO-DIRECTION study-

Scientific Title:Acronym

-CRYO-DIRECTION study-

Region

Japan


Condition

Condition

interstitial lung disease

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and diagnostic utility of ultrathin cryobiopsy using a 1.1-mm cryoprobe with a direct specimen retrieval technique through the therapeutic bronchoscope working channel for bronchoscopic diagnosis of ILD.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety (bleeding)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with pulmonary lesions, such as ground-glass opacities or infiltrative shadows, identified on chest computed tomography (CT), who are scheduled to undergo ultrathin cryobiopsy using a 1.1-mm cryoprobe under a therapeutic bronchoscope to determine the treatment strategy.
Age>=20 years.
Written informed consent for participation in this study obtained from the patient.

Key exclusion criteria

Patients strongly suspected of having lung cancer based on elevated tumor markers in blood tests or imaging findings.
Lesions located in the inner one-third of the lung field from the hilum.
Patients who require additional bronchoscopic procedures other than bronchoalveolar lavage and cryobiopsy before the examination.
Lesions adjacent to major blood vessels.
Lesions in which the distance from the planned cryobiopsy site to the pleura is less than 1 cm.
Pregnant women or women who may be pregnant.
Patients receiving anticoagulant or antiplatelet therapy who cannot discontinue these medications prior to the procedure.
Patients with a marked bleeding tendency.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Takigawa

Organization

NHO Okayama Medical Center

Division name

Department of Respiratory Medicine

Zip code

701-1192

Address

1711-1 Okayamashi Kitaku Tamasu

TEL

086-294-9911

Email

tacky1024@gmail.com


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Takigawa

Organization

NHO Okayama Medical Center

Division name

IRB

Zip code

701-1192

Address

1711-1 Okayamashi Kitaku Tamasu

TEL

086-294-9911

Homepage URL


Email

tacky1024@gmail.com


Sponsor or person

Institute

Department of Clinical Research, National Hospital Organization Okayama Medical Center, Okayama, Japan

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Clinical Research, National Hospital Organization Okayama Medical Center, Okayama, Japan

Address

1711-1 Okayamashi Kitaku Tamasu

Tel

0862949911

Email

tacky1024@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 03 Month 01 Day

Date of IRB

2026 Year 06 Month 09 Day

Anticipated trial start date

2026 Year 06 Month 10 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Multicenter Observational Study
This prospective study aims to investigate the safety and diagnostic outcomes of the Direct Retrieval through the Therapeutic Bronchoscope Channel Technique , which utilizes a 1.1-mm cryoprobe for ultrathin cryobiopsy, in patients with abnormal chest imaging findings, including ground-glass opacities and pulmonary infiltrates, who undergo the procedure as part of routine clinical bronchoscopy.


Management information

Registered date

2026 Year 06 Month 10 Day

Last modified on

2026 Year 06 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069964